Yüklüyor......
Comparison of the RECIST 1.0 and RECIST 1.1 in Non-Small Cell Lung Cancer Treated with Cytotoxic Chemotherapy
Background : The impact of the RECIST 1.1 on the selection of target lesions and assessment of tumor response was not evaluated in patients with advanced NSCLC who received cytotoxic chemotherapy. Methods: We reviewed medical records of patients with advanced NSCLC who received first-line chemothera...
Kaydedildi:
| Yayımlandı: | J Cancer |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Ivyspring International Publisher
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4466415/ https://ncbi.nlm.nih.gov/pubmed/26078796 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.11794 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|